Responsibilities for Implementation of NBM-PMU which includes - monitoring of all grantees of your focus area engaging experts both technical and financial, working closely with the Scientific and Technical Advisory groups for project review and supervising grant management activities.
Review of approved vendor list in-line with submitted, current DMF. Review of Raw materials, Packing materials specification and analytical procedures. Preparation of ODMF, Technical package as per customer requirement.
M.Sc, M.Tech, M.Pharm IPR from a recognized University. The incumbent should have sound knowledge of Patent Act, 1970 and should possess five years post qualification experience in dealing with issues like filling of Patent, Design, Copy Right & Trade Marks.
M.Sc, M. Tech in Life Science or equivalent with at least 4 years hands on research experience in bioinformatic analysis of genomic, met agenomic data or Ph.D. in Life Science or equivalent with expertise in bioinformatic s of genomic, met agenomic data
To design and implement integrated strategies, linking appropriate chromatography and mass spectrometry tools, to perform a qualitative and quantitative assessment of product related variants and impurities.
PG Professional degree in Life Sciences, Pharmacology, Chemical Sciences or equivalent, M.Tech, M.Pharma or equivalent with two 2 years of post-qualification experience in the field of bioanalytical chemistry with emphasis on drug metabolism and pharmacokinetic DMPK studies.
A Masters M.Pharm or M.Sc. or M.Tech. or M.E. or Bachelors B.Tech or B.E. or B.Pharm. An understanding of the Process Development and Industrial perspective of Biotherapeutics/ Biosimilars. Basic understanding of analytical techniques, statistical analysis, data management and analysis.
The candidate should be M. Sc. Ag., M. Sc.,MTech Biotechnology, Botany,Life Sciences,Plant Sciences,M.Pharm,Bachelor of Engg.,Technology B.E.,B. Tech. or equivalent degree with high academic attainment with 1st class in Graduate and Post Graduate examination.